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Background: The homotypic cell–cell adhesion molecule EpCAM
is a transmembrane protein expressed on the surface of nearly all
epithelia. Originally it was identified as a tumor specific antigen
overexpressed in various types of carcinomas. Claudin-7 is a
transmembrane protein known as one of the major components
of tight junctions. We recently demonstrated a direct interaction
between EpCAM and Claudin-7 on several carcinomas and non-
transformed tissue of the gastrointestinal tract that was not
restricted to tight junctions.
Methods: The ectopic expression of EpCAM and Claudin-7 in
HEK293T cells was used to characterize the interaction of both
proteins and to analyze the influence of Claudin-7 on different
known biological properties of EpCAM like oligomerisation or
association of EpCAM with glycolipid-enriched membrane micro-
domains (GEM).
Results: The binding site of EpCAM for Claudin-7 could be
restricted to the extracellular cystein-poor region or the trans-
membrane domain of EpCAM. Interestingly the oligomerisation
of EpCAM is decreased in the presence of Claudin-7. Furthermore,
both EpCAM and Claudin-7 are recovered from GEMs enriched in
tetraspanins, whereby Claudin-7 is required for the EpCAM
recruitment into GEMs.
Conclusions: Though the functional consequences of the inter-
action of EpCAM with Claudin-7 remain to be explored both
observations offer starting points for an understanding of the
functional relevance of this complex. First, by interfering with
the oligomeric state of EpCAM Claudin-7 could well influence
EpCAM mediated cell–cell-adhesion properties. Second, by
recruiting of EpCAM to GEM associated signaling platforms Clau-
din-7 might facilitate the induction of downstream signaling cas-
cades, yet to be identified.
doi:10.1016/j.ejcsup.2006.04.098
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Background: One of the most common properties of cancer is
genomic instability. Possible causes include centrosome aberra-tions and defects of the DNA damage response (DDR). ATR-Sec-
kel syndrome and ataxia-teleangiectasia are autosomal
recessive disorders associated with hematologic malignancies,
which share the feature of genomic instability and are caused
by DDR defects, namely by a hypomorphic ATR mutation and
inactivating ATM mutations, respectively. A downstream sub-
strate of both ATM and ATR is the nuclear checkpoint kinase
Chk1, which we have recently shown to localize to interphase
centrosomes and thereby negatively regulate entry into mitosis
by preventing premature activation of cyclin B-Cdk1 [Nat Cell
Biol 2004;6:884–91].
Methods: We assessed centrosomal Chk1 by immunofluores-
cence in different fibroblast cell lines with and without DNA-
damaging treatment.
Results: DNA damage by ultraviolet radiation or hydroxyurea
enhanced the centrosomal localization of Chk1. In fibroblasts
derived from ATR-Seckel or ataxia-teleangiectasia patients, this
DNA damage-dependent centrosomal accumulation of Chk1
was more pronounced as compared to control fibroblasts. Accord-
ingly, this phenotype is not dependent on ATR or ATM.
Conclusion: Centrosomal accumulation of Chk1 in response to
DNA damage leading to G2/M arrest may contribute a novel regu-
latory mechanism to the DDR armamentarium.
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Background: Fibroblast growth factors (FGFs) and their specific
receptors (FGFRs) are involved in several biological processes like
angiogenesis and cell proliferation. We showed that the IIIc-vari-
ant of the human FGFR1 is able to induce the transforming poten-
tial in TAKA-1 ductal pancreatic cells. We also demonstrated that
the now completely cloned human FGFR1-IIIb-variant is a func-
tional FGFR, which reduces growth of TAKA-1 ductal and PANK-1
pancreatic carcinoma cells. The aim of this study was to investi-
gate the influence of FGFR1-IIIb-expression on transforming
potential of pancreatic carcinoma cells.
Methods: Colony-forming rate, cell mobility in real-time-micros-
copy and ability of invasion in a Boyden-chamber were assessed
in vitro. Tumor formation rate of either PANC-1 control clones
(PN5, PN6) or FGFR1-IIIb expressing clones was monitored after
establishment in nude mice.
Results: FGFR1-IIIb expressing clones showed minor growth and
lower colony forming rate of >70% compared to control clones
and a significant reduction of cell mobility in vitro. Ability of inva-
sion was lowered to >75%. In vivo 14 of 16 (PF4) and 16 of 24 (PF40)
FGFR1-IIIb-clone injected areas showed solid tumors within 6
weeks. By comparison almost all areas being injected with control
clones formed solid tumors (8 of 8 for PN5, 22 of 24 for PN6). Total
amount of solid tumors as well as volume increase of the FGFR1-
IIIb expressing tumors was reduced.
